Teleflex Incorporated ($TFX) Stock Forecast: Down 3.5% Today

What is Teleflex Incorporated?

Teleflex Inc. (TFX) is a key player in the medtech industry, specializing in products for minimally invasive care, vascular access, anesthesia, and interventional tools. The company's focus on safety, simplicity, and standardization has made it an attractive option for investors seeking reliable revenue streams.

Why is Teleflex Incorporated going down?

TFX stock is down 3.5% on Feb 12, 2026 17:07

• The bearish movement in Teleflex Inc. (TFX) today could be attributed to the sudden departure of CEO Liam Kelly, leading to governance and disclosure concerns among investors.
• The legal review initiated by Pomerantz LLP following the CEO exit may have raised apprehensions about potential securities violations or unlawful business practices, adding to the negative sentiment surrounding the stock.
• Despite the promising growth forecasts in the medtech sector, the uncertainty surrounding leadership and governance issues at Teleflex could have overshadowed the company's competitive edge and procedure-linked revenue prospects, resulting in the bearish market movement.

TFX Price Chart

TFX Technical Analysis

TFX News

Teleflex Inc.: The Quiet Medtech Workhorse Powering the Future of Minimally Invasive Care

Teleflex Inc. is a critical medtech company that underpins modern minimally invasive care with its product ecosystem in vascular access, anesthesia, and interventional tools. The company focuses on safety, simplicity, and standardization, offering solutions that reduce complications and improve efficiency in hospitals. Its competitive edge lies in clinical nuance, workflow-oriented kits, and economic benefits through reduced downstream complication costs, making it an attractive prospect for investors seeking reliable, procedure-linked revenue.

https://www.ad-hoc-news.de/boerse/news/ueberblick/teleflex-inc-the-quiet-medtech-workhorse-powering-the-future-of/68574286

Laryngeal Mask Market Is Going to Boom |• Ambu A/S • Teleflex Incorporated

Worldwide Market Reports has published an in-depth research study on the "Laryngeal Mask Market Size and Forecast 2026-2033," analyzing by manufacturers, regions, product types, and applications. The report utilizes both primary and secondary research methods, offering comprehensive coverage of market drivers, growth opportunities, restraints, and challenges. It includes insights into competitive landscapes, regional performance, revenue forecasts, and segmentation analysis, highlighting key players like Ambu A/S and Teleflex Incorporated.

https://www.openpr.com/news/4386451/laryngeal-mask-market-is-going-to-boom-ambu-a-s-teleflex

Needle Holder Market Is Going to Boom | Teleflex Incorporated • Smith & Nephew • Conmed Corporation

Coherent Market Insights has released a comprehensive research report on the Needle Holder Market, forecasting substantial growth between 2026 and 2033. The report analyzes key market trends, drivers, challenges, and the competitive landscape, covering market size, revenue, and CAGR. It also identifies top companies, market segmentation by product type and region, and provides strategic insights for businesses.

https://www.openpr.com/news/4384428/needle-holder-market-is-going-to-boom-teleflex-incorporated

Teleflex Inc (TFX) Shares Gap Down to $104.71 on Feb 9

Teleflex Inc (TFX) shares dropped 3.42% to $104.71 on Feb 9, trading significantly below its 52-week high but slightly above its 52-week low. Analysts forecast an average target price of $135.22, implying a 29.14% upside, while GuruFocus estimates a fair value of $286.34, suggesting a 173.46% upside. The consensus brokerage recommendation for TFX is "Hold."

https://www.gurufocus.com/news/8599067/teleflex-inc-tfx-shares-gap-down-to-10471-on-feb-9

Teleflex CEO Exit And Legal Review Reshape Governance Risk For Investors

Pomerantz LLP has launched an investigation into Teleflex (NYSE:TFX) following the abrupt departure of CEO Liam Kelly, raising concerns about potential securities violations or unlawful business practices. This leadership change and legal scrutiny increase governance and disclosure risk for investors, especially as the medical technology company navigates softer demand and integrates acquisitions. Shareholders will be watching how the board addresses succession, communicates with the market, and resolves the investigation.

https://www.sahmcapital.com/news/content/teleflex-ceo-exit-and-legal-review-reshape-governance-risk-for-investors-2026-02-06

Trending Today

Shiba Inu ($SHIB) Crypto Forecast: Up 6.1% Today

Bitcoin ($BTC) Crypto Forecast: Up 5.0% Today

Ethereum ($ETH) Crypto Forecast: Up 6.6% Today

Solana ($SOL) Crypto Forecast: Up 7.9% Today

Albemarle Corporation ($ALB) Stock Forecast: Up 5.8% Today

Sonos Inc. ($SONO) Stock Forecast: Down 5.2% Today

Franco-Nevada Corp. ($FNV) Stock Forecast: Up 5.1% Today

Applied Materials Inc. ($AMAT) Stock Forecast: Up 7.6% Today

Rocket Companies Inc ($RKT) Stock Forecast: Up 5.1% Today

Jetblue Airways Corporation ($JBLU) Stock Forecast: Up 5.4% Today

Teleflex Incorporated Price History

15.08.2025 - TFX Stock was down 5.1%

• The enrollment of the first patient in the DUBSTENT DIABETES trial, focusing on improving PCI outcomes for diabetic patients, could be seen as a positive development for TFX.
• However, the market might have reacted negatively to the uncertainty surrounding the trial's success and potential regulatory hurdles.
• Investors may be concerned about the competitive landscape in the diabetes treatment market, leading to a sell-off of TFX shares.
• Overall, the bearish movement in TFX's stock could be attributed to the mixed sentiments surrounding the trial's outcomes and the competitive pressures in the industry.

09.11.2025 - TFX Stock was up 8.8%

• The bullish movement in TFX may be linked to a theory emphasizing the company's strategic turnaround and potential upside.
• An analysis suggests TFX could be undervalued by up to 74.2%, sparking investor interest and increased buying activity.
• The recent acquisition of BIOTRONIK's Vascular Intervention business and positive FY 2025 EPS guidance by the company likely contributed to the bullish momentum.
• Despite concerns from analysts lowering price targets and ratings, the overall positive outlook on TFX's growth prospects and strategic initiatives appears to have driven the stock higher.

09.11.2025 - TFX Stock was up 10.4%

• The bullish movement in TFX stock today can be attributed to the completion of the $2.03 billion sale of its Acute Care, Interventional Urology, and OEM businesses. This strategic divestiture is part of Teleflex's plan to optimize its portfolio and focus on core markets, which has likely been well-received by investors.
• The sale will provide Teleflex with approximately $1.8 billion in net proceeds, which the company plans to utilize for returning capital to shareholders through share repurchases and paying down debt. This capital allocation strategy could be seen as a positive signal by investors, driving up the stock price.
• The acquisition of Teleflex Medical OEM by private equity firms Montagu and Kohlberg for $1.5 billion is also a significant development. This move is expected to position Teleflex Medical OEM as an independent global contract developer and manufacturer, potentially unlocking new growth opportunities and enhancing innovation capabilities.
• Overall, the market seems to be reacting positively to Teleflex's strategic initiatives and the potential for accelerated growth and value creation following the divestiture and acquisition deals.

08.04.2025 - TFX Stock was up 5.4%

• A Board Member at Teleflex, Duncan, displayed confidence in the company's future prospects by acquiring stock options.
• Teleflex's Q1 earnings exceeded expectations due to its diverse product portfolio and strong performance in key segments, fostering investor optimism.
• Despite an investigation by the Rosen Law Firm concerning potential securities claims, Teleflex's stock performance remained largely unaffected, with positive earnings results taking precedence.

08.00.2026 - TFX Stock was down 11.7%

• The decrease in TFX stock value today could be linked to an average "Reduce" rating provided by twelve analysts, signaling cautious predictions about the company's future performance.
• Despite posting strong Q3 earnings and optimistic forecasts for FY2025, the market seems to have reacted negatively to the rating downgrade.
• Investor apprehension about potential obstacles or challenges that could hinder Teleflex's growth trajectory could explain the downward trend in the stock price.
• Uncertainties surrounding competition, regulatory modifications, or other variables that might impact Teleflex's financial stability and market standing could be factoring into the current market sentiment.

25.08.2025 - TFX Stock was down 5.0%

• The market sentiment towards TFX has been bearish today.
• The decrease in TFX stock today might be linked to a recent comparison between TFX and PEN, discussing the preferable investment option. The resulting uncertainty potentially prompted some investors to sell their TFX shares, contributing to the bearish trend.

11.10.2025 - TFX Stock was up 5.1%

• The upward trend in TFX stock may be linked to its third-quarter earnings report surpassing analyst forecasts.
• Teleflex's announcement of a quarterly dividend could also be a contributing factor to the positive outlook among investors, particularly appealing to those seeking dividends.
• The combination of outperforming earnings projections and the introduction of a dividend likely strengthened investor confidence in Teleflex's financial stability and future potential, driving the increase in the stock price.

22.00.2026 - TFX Stock was up 5.4%

• TFX stock experienced a strong bullish movement today despite recent negative developments and a 52-week low, possibly due to:
• Analysts' positive outlook on the company's return to profitability this year and its undervalued status.
• The announcement of the sale of three businesses for $2.03 billion and a $1 billion share repurchase program, signaling strategic moves to boost shareholder value.
• Investors may be optimistic about the company's future despite the CEO's exit, lower revenue outlook, and legal scrutiny, as evidenced by the stock's upward momentum.

12.01.2026 - TFX Stock was down 3.5%

• The bearish movement in Teleflex Inc. (TFX) today could be attributed to the sudden departure of CEO Liam Kelly, leading to governance and disclosure concerns among investors.
• The legal review initiated by Pomerantz LLP following the CEO exit may have raised apprehensions about potential securities violations or unlawful business practices, adding to the negative sentiment surrounding the stock.
• Despite the promising growth forecasts in the medtech sector, the uncertainty surrounding leadership and governance issues at Teleflex could have overshadowed the company's competitive edge and procedure-linked revenue prospects, resulting in the bearish market movement.

08.06.2025 - TFX Stock was up 1.9%

• The acquisition of BIOTRONIK's vascular intervention business by Teleflex (TFX) resulted in a 2.9% increase in TFX stock price.
• This acquisition is viewed as a strategic move to improve TFX's presence in cath lab and its innovation pipeline.
• Investor confidence in TFX's growth prospects was positively influenced by this acquisition.

06.10.2025 - TFX Stock was down 13.1%

• The announcement of a quarterly dividend may have led to a bearish movement in the stock.
• Investors might be concerned that the dividend payout could impact the company's cash reserves or future growth prospects.
• The market may be reacting negatively to the dividend news, possibly indicating a shift in investor sentiment towards the stock.
• Overall, the bearish movement in TFX could be attributed to profit-taking by investors following the dividend announcement.

31.06.2025 - TFX Stock was up 6.6%

• TFX stock saw a significant increase in value today.
• The company's Q2 earnings and revenues exceeded expectations, reflecting robust financial results.
• The recent declaration of a quarterly dividend by Teleflex's Board of Directors may have enhanced investor trust and drawn more interest from potential buyers to the stock.
• Both the impressive earnings performance and the dividend declaration likely contributed to the positive movement in TFX's stock price.